Federal Register / Vol. 69, No. 220 / Tuesday, November 16, 2004 / Notices 67151

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel Microbicide Design and 

Development Teams. 

Date: December 1, 2004. 

Time: 12:30 p.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817. 

Contact Person: Gerald L. McLaughlin, 

PhD, Scientific Review Administrator, 

Scientific Review Program, Division of 

Extramural Activities, DHHS/NIH/NIAID, 

6700B Rockledge Drive, MSC 7616, Bethesda, 

MD 20892, (301) 435–2766, gm145@nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS)

Dated: November 8, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–25351 Filed 11–15–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health, 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel 

Psychometric (IRT) Models for Clinical 

Studies. 

Date: December 1, 2004. 

Time: 3:43 p.m. to 5:20 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (telephone 

conference call). 

Contact Person: Mark Czarnolewsi, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, Neuroscience Center, 

6001 Executive Blvd., Room 8122, MSC 9667, 

Bethesda, MD 20892–9667, (301) 435–4582, 

mczarnol@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientists Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientists Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS)

Dated: November 8, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–25352] Filed 11–15–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SEP to 

Review NAED Member Conflict 

Applications. 

Date: November 11, 2004. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call). 

Contact Person: Ranga V. Srinivas, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1167, srinivar@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Environmental Toxicology. 

Date: November 12, 2004. 

Time: 1:30 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call). 

Contact Person: Lee S. Mann, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7848, Bethesda, MD 20892, (301) 435–

0677, mannl@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SEP to 

Review AMCB Member Conflicts. 

Date: November 18, 2004. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call). 

Contact Person: Ranga V. Srinivas, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1167, srinivar@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SEP to 

Review NAED Member Conflict 

Applications. 

Date: November 23, 2004. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call). 

Contact Person: Ranga V. Srinivas, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1167, srinivar@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 

EMNR G (02) Diabetes and Obesity. 

Date: November 24, 2004. 

Time: 10:30 a.m. to 12:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

67152 Federal Register / Vol. 69, No. 220 / Tuesday, November 16, 2004 / Notices 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call). 

Contact Person: Abubakar A. Shaikh, PhD, 

DVM, Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 6168, MSC 7892, Bethesda, MD 20892, 

(301) 435–1042, shaikha@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SEP to 

Review AOIC Member Conflicts. 

Date: November 24, 2004. 

Time: 11 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call).

Contact Person: Ranga V. Srinivas, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1167, srinivar@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel High 

Resolution Electron Microscopy. 

Date: November 29, 2004. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call). 

Contact Person: Richard D. Rodewald, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5142, 

MSC 7840, Bethesda, MD 20892, (301) 435–

1024, rodewalr@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Neural 

Engineering. 

Date: December 1, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sofitel Lafayette Square Washington, 

806 15th Street, NW., Washington, DC 20005. 

Contact Person: Mary Custer, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4136, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1164, custerm@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Pelvic Floor 

Physiology. 

Date: December 1, 2004. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call). 

Contact Person: M. Chris Langub, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4112, 

MSC 7814, Bethesda, MD 20892, (301) 496–

8551, langubm@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel PAR–03–137 

Topical Microbicides. 

Date: December 8–10, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, Washington, DC 20037. 

Contact Person: Ranga V. Srinivas, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5222, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1167, srinivar@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel ZRG1 ONC 

F (02) Gene Expression. 

Date: December 13, 2004. 

Time: 1:30 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone conference call).

Contact Person: Marcia Litwack, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6206, 

MSC 7804, Bethesda, MD 20892, (301) 435–

1719, litwackm@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict—Neurogenesis. 

Date: December 14, 2004. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(telephone conference call). 

Contact Person: Carole L. Jelsema, PhD, 

Chief and Scientific Review Administrator, 

MDCN Scientific Review Group, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4146, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1248, jelsemac@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Pharmacogenetics and Bioinformatics. 

Date: December 14–15, 2004. 

Time: 5 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Four Points by Sheraton Bethesda, 

8400 Wisconsin Avenue, Bethesda, MD 

20814. 

Contact Person: Barbara Whitmarsh, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2206, 

MSC 7890, Bethesda, MD 20892, (301) 435–

4511, whitmarshb@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Angiotensin 

Receptors. 

Date: December 17, 2004. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(telephone conference call). 

Contact Person: Joyce C. Gibson, DSC, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4130, 

MSC 7814, Bethesda, MD 20892, (301) 435–

4522, gibsonj@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 RUS–

E (02) Renal Urology Special Member 

Conflicts Meeting. 

Date: December 20, 2004. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Aftab A. Ansari, PhD, 

Health Scientist Administrator, National 

Institutes of Health, Center for Scientific 

Review, 6701 Rockledge Drive, Room 4108, 

MSC 7814, Bethesda, MD 20892, (301) 435–

1173, ansaria@csr.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS)

Dated: November 8, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–25346 Filed 11–15–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 

Substance Abuse and Mental Health 

Services Administration will publish 

periodic summaries of proposed 

projects. To request more information 

on the proposed projects or to obtain a 

copy of the information collection 

plans, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Comments are invited on: (a) Whether 

the proposed collections of information 

are necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology.